Geftinat Tablet

Geftinat Tablet Specification

Dosage Form
Tablet

Indication
Non-small cell lung cancer (NSCLC)

Salt Composition
Gefitinib (250 mg)

Feature
Oral anticancer agent for advanced and metastatic NSCLC

Ingredients
Gefitinib, Excipients

Application
Used in targeted cancer therapy

Physical Color/Texture
White to off-white, round film-coated tablet

Fermentation Smell
Odorless

Storage Instructions
Store at room temperature (15°C to 30°C), keep away from direct light and moisture

Shelf Life
24 months

Caution
Monitor liver function tests, use with caution in patients with impaired hepatic or renal function

Therapeutic Class
Antineoplastic agent

Strength
250 mg

Prescription Status
Prescription only medication

Packaging Size
30 tablets per bottle

Contraindications
Pregnancy, lactation, hypersensitivity to Gefitinib

Expiry Date
Marked on packaging

Route of Administration
Oral

Administration
Oral, once daily

ATC Classification
L01XE02

About Geftinat Tablet

In our extensive medicinal products, we are offering premium quality Geftinat Tablet. The offered tablet is processed at our vendor's end with the use of high grade chemical formulations in precise composition and is formulated in variety of tablet. The offered tablet is an anti-cancer medicine, widely used for the treatment of lung cancer. Apart from this, provided tablet is recommended by doctors for its healing ability. Our precious clients can avail this Geftinat Tablet at reasonable price.

Features :

Anti-allergic
Balanced composition
Accurate formulation
Immensely miscible

Details:

We are a prominent trader, supplier, exporter and distributor of Geftinat Tablet to our highly valued clients. It is an anti- cancer medicine composed of qualitative ingredients in apt quantities at our vendors' unit under professional guidance. Geftinat Tablet is highly effective but should be used after consulting a doctor when prescribed. Clients can avail it from us at highly reasonable prices in the market.

GEFTINAT 250mg (Gefitinib) is a doctor prescribed medication utilized as a part of the treatment of non-little cell lung malignancy. It is utilized as a part of patients in which it has spread to different parts of the body, who have strange epidermal development factor receptor (EGFR) qualities, and who have not had past treatment for tumor. It meddles with the development and spread of tumor cells in the body.

Maker : Natco Pharma Ltd.

Additional INFORMATION :

Qualities available : 250 mg tablets
Capacity : Store in a cool, dry place, shielded from light and dampness

Dosages:

The prescribed every day measurement of GeftiNat (Iressa or Gefitinib) is one 250 mg tablet with or without sustenance.
Higher measurements don't give a superior reaction and cause expanded poisonous quality.

Indications :

Most normal Indications are Nausea, Rash, Vomiting, Weakness, Loss of hunger, Dry skin, Diarrhea, Stomatitis (Inflammation of the mouth).

PACK SIZE : Pack of 30 tablets

Targeted Treatment for NSCLC

Geftinat Tablet offers a precise therapeutic approach for patients with advanced and metastatic non-small cell lung cancer. By specifically targeting cancerous cells, it helps in reducing tumor progression with a manageable safety profile. The oral tablet form enables convenient once-daily dosing, improving compliance while maintaining effective inhibition of tumor growth.

Safe and Convenient Oral Administration

Administered orally, Geftinat provides a comfortable alternative to intravenous cancer therapies. Patients are instructed to take one tablet daily at a consistent time, as prescribed by their healthcare professional. With its odorless, film-coated design, the tablet ensures ease of use and minimal disruption to daily activities.

FAQs of Geftinat Tablet:

Q: How should Geftinat Tablet be taken for optimal effectiveness?

A: Geftinat Tablet should be taken orally once daily, ideally at the same time each day, with or without food. It is vital to follow the prescribing doctors instructions for duration and dosage.

Q: What is the primary indication for Geftinat Tablet?

A: Geftinat Tablet is indicated for targeted therapy in patients with advanced or metastatic non-small cell lung cancer (NSCLC), helping to inhibit cancer cell growth.

Q: When should Geftinat Tablet not be used?

A: Geftinat Tablet is contraindicated in individuals who are pregnant, breastfeeding, or have a known hypersensitivity to Gefitinib. Those with severe liver or kidney impairment should use it cautiously.

Q: Where should Geftinat Tablet be stored for maximum stability?

A: Store Geftinat Tablet at room temperature between 15C to 30C, away from direct light and moisture, to maintain its potency throughout its shelf life.

Q: What should be monitored during the treatment process with Geftinat Tablet?

A: Patients taking Geftinat should have their liver function tests routinely monitored, especially those with impaired hepatic or renal function, as directed by their healthcare provider.

Q: What are the benefits of using Geftinat Tablet in cancer therapy?

A: Geftinat Tablet delivers targeted anticancer action, which can slow the progression of NSCLC and improve patient outcomes, all with the convenience of oral administration.

Get Latest Price